Summary
Ten patients with persistent ventricular arrhythmia were studied in a comparison of the antiarrhythmic efficacy of N-acetylprocainamide (NAPA) and procainamide (PA). Each patient performed three exercise tests for 40 min., on different days, with submaximal and fixed work loads. During the first exercise test no drug was administered. During the following two tests PA and NAPA, respectively, were administered by intravenous infusion. The electrocardiogram was continuously recorded and was analyzed minute by minute. Blood samples for determination of plasma drug concentration were frequently collected. Exercise alone did not significantly change the incidence of arrhythmia. Both PA and NAPA showed a similar and significant antiarrhythmic effect. A blood pressure fall was seen in two patients after administration of each drug. No other adverse reaction was observed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Atkinson, A.J., Jr.: Personal communication (1977)
Atkinson, A.J. Jr., Lee, W.-K., Quinn, M.L., Kushner, W., Nevin, M.J., Strong, J.M.: Dose-ranging trial of N-acetyl-procainamide in patients with premature ventricular contractions. Clin. Pharmacol. Ther.21, 575–587 (1977)
Austen, W.G., Moran, J.M.: Cardiac and peripheral vascular effects of lidocaine and procainamide. Am. J. Cardiol.16, 701–707 (1965)
Crawford, M., O'Rourke, R.A., Ramakrishna, N., Henning, H., Ross, J.: Comparative effectiveness of exercise testing and continuous monitoring for detecting arrhythmias in patients with previous myocardial infarction. Circulation50, 301–305 (1974)
Drayer, D.E.: Personal communication (1978)
Drayer, D.E., Reidenberg, M.M., Sevy, R.W.: N-acetylprocainamide: An active metabolite of procainamide. Proc. Soc. Exp. Biol. Med.146, 358–363 (1974)
Graffner, C., Jansson, R.-M., Lagerström, P.O., Persson, B.-A.: Disposition of procainamide and its N-acetylated metabolite after acute i. v. infusion in man determined by high-speed liquid chromatography. Eur. J. Drug Metab. Pharmacokin.1, 29–36 (1977)
Henningsen, N.C., Cederberg, A., Hansson, A., Johansson, B.W.: Effects of long-term treatment with procaine amide. Acta med. scand.198, 475–482 (1975)
Jelinek, M.V., Lown, B.: Exercise stress testing for exposure of cardiac arrhythmia. Progr. Cardiovasc. Dis.16, 497–522 (1974)
Karlsson, E., Molin, L., Norlander, B., Sjöqvist, F.: Acetylation of procaine amide in man studied with a new gas chromatographic method. Br. J. clin. Pharmacol.1, 467–475 (1974)
Karlsson, E., Kinman, A., Sonnhag, C.: Comparative evaluation of intravenous phenytoin, procainamide and practolol in the acute treatment of ventricular arrhythmias. Europ. J. clin. Pharmacol.11, 1–6 (1977)
Koch-Weser, J., Klein, S.W.: Procaine amide dosage schedules, plasma concentrations and clinical effects. J. Am. med. Assoc.215, 1454–1460 (1971)
Kosowsky, B.D., Taylor, J., Lown, B., Ritchie, R.F.: Long-term use of procaine amide following acute myocardial infarction. Circulation47, 1204–1210 (1973)
Lee, W.-K., Strong, J.M., Kehoe, R.F., Dutcher, J.S., Atkinson, A.J.Jr.: Antiarrhythmic efficacy of N-acetylprocainamide in patients with premature ventricular contractions. Clin. Pharmacol. Ther.19, 508–514 (1976)
Lown, B., Wolf, M.: Approaches to sudden death from coronary heart disease. Circulation44, 130–142 (1971)
McClendon, R.L., Hansen, W.R., Kinsman, J.M.: Hemodynamic changes following procaine amide administered intravenously. Am. J. med. Sci.222, 375–381 (1951)
Reidenberg, M.M., Drayer, D.E., Levy, M., Warner, H.: Polymorphic acetylation of procainamide in man. Clin. Pharmacol. Ther.17, 722–730 (1975)
Sonnhag, C., Karlsson, E.: Comparative-evaluation of procainamide and its main metabolite, N-acetylarocainamide, in the acute treatment of ventricular arrhythmias. Br. J. clin. Pharmacol.4, 632 (1977)
Strong, J.M., Dutcher, J.S., Lee, W.-K., Atkinson, A.J.Jr.: Pharmacokinetics in man of the N-acetylated metabolite of procainamide. J. Pharmacokinet. Biopharm.3, 223–235 (1975a)
Strong, J.M., Dutcher, J.S., Lee, W.-K., Atkinson, A.J.Jr.: Absolute bioavailability in man of N-acetylprocainamide determined by a novel stable isotope method. Clin. Pharmacol. Ther.18, 613–622 (1975b)
Author information
Authors and Affiliations
Additional information
A preliminary account of this study appeared as an abstract in Br. J. clin. Pharmacol.4, 632 (1977)
Rights and permissions
About this article
Cite this article
Sonnhag, C., Karlsson, E. Comparative antiarrhythmic efficacy of intravenous N-acetylprocainamide and procainamide. Eur J Clin Pharmacol 15, 311–317 (1979). https://doi.org/10.1007/BF00558433
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00558433